GODAVARIB

Godavari Biorefineries Share Price

 

 

Invest in Godavari Biorefineries with 1.91X leverage

Invest with MTF
Godavari Biorefineries live price: ₹285.7. It opened at ₹275 vs previous close ₹279; intraday high/low: ₹289/₹273. The 50 & 200 DMA stand at ₹273.34/₹264.55.

Godavari Biorefineries Performance

  • Low
  • ₹273
  • High
  • ₹289
  • 52 Week Low
  • ₹145
  • 52 Week High
  • ₹349
  • Open Price₹275
  • Previous Close₹279
  • Volume382,192
  • 50 DMA₹273.34
  • 100 DMA₹269.58
  • 200 DMA₹264.55

Investment Returns

  • Over 1 Month + 16.14%
  • Over 3 Month + 19.04%
  • Over 6 Month -0.08%
  • Over 1 Year + 86.71%

Smart Investing Starts Here Start SIP with Godavari Biorefineries for Steady Growth!

Invest Now

Godavari Biorefineries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 64.8
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 1,462
  • P/B Ratio
  • 2
  • Average True Range
  • 16.36
  • EPS
  • 10.53
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.18
  • RSI
  • 54.73
  • MFI
  • 84.98

Godavari Biorefineries Financials

Godavari Biorefineries Technicals

EMA & SMA

Current Price
₹285.70
+ 7 (2.51%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹279.07
  • 50 Day
  • ₹273.34
  • 100 Day
  • ₹269.58
  • 200 Day
  • ₹264.55

Resistance and Support

282.7 Pivot Speed
  • R3 308.80
  • R2 299.10
  • R1 292.40
  • S1 276.00
  • S2 266.30
  • S3 259.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Godavari Biorefineries Ltd has an operating revenue of Rs. 2,003.34 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company has a reasonable debt to equity of 31%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 80 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Godavari Biorefineries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-11 Quarterly Results
2025-08-07 Quarterly Results
2025-05-24 Audited Results
2025-02-08 Quarterly Results

Godavari Biorefineries F&O

Godavari Biorefineries Shareholding Pattern

63.31%
10.02%
0.86%
20.03%
5.78%

About Godavari Biorefineries

  • NSE Symbol
  • GODAVARIB
  • BSE Symbol
  • 544279
  • Chairman & Managing Director
  • Mr. Samir Shantilal Somaiya
  • ISIN
  • INE497S01012

Similar Stocks to Godavari Biorefineries

Godavari Biorefineries FAQs

Godavari Biorefineries share price is ₹285 As on 05 March, 2026 | 00:16

The Market Cap of Godavari Biorefineries is ₹1462.1 Cr As on 05 March, 2026 | 00:16

The P/E ratio of Godavari Biorefineries is 64.8 As on 05 March, 2026 | 00:16

The PB ratio of Godavari Biorefineries is 2 As on 05 March, 2026 | 00:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23